000 02502 a2200781 4500
005 20250518030027.0
264 0 _c20200207
008 202002s 0 0 eng d
022 _a1538-7445
024 7 _a10.1158/0008-5472.CAN-18-2861
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeisner, Jörn
245 0 0 _aPreclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in
_h[electronic resource]
260 _bCancer research
_c05 2019
300 _a2367-2378 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
650 0 4 _aCell Cycle
650 0 4 _aCell Proliferation
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aMutation
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aProto-Oncogene Proteins c-akt
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Proteins p21(ras)
_xgenetics
650 0 4 _aPyridones
_xpharmacology
650 0 4 _aPyrimidinones
_xpharmacology
650 0 4 _aTumor Cells, Cultured
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aLandel, Ina
700 1 _aReintjes, Christoph
700 1 _aUhlenbrock, Niklas
700 1 _aTrajkovic-Arsic, Marija
700 1 _aDienstbier, Niklas
700 1 _aHardick, Julia
700 1 _aLadigan, Swetlana
700 1 _aLindemann, Marius
700 1 _aSmith, Steven
700 1 _aQuambusch, Lena
700 1 _aScheinpflug, Rebekka
700 1 _aDepta, Laura
700 1 _aGontla, Rajesh
700 1 _aUnger, Anke
700 1 _aMüller, Heiko
700 1 _aBaumann, Matthias
700 1 _aSchultz-Fademrecht, Carsten
700 1 _aGünther, Georgia
700 1 _aMaghnouj, Abdelouahid
700 1 _aMüller, Matthias P
700 1 _aPohl, Michael
700 1 _aTeschendorf, Christian
700 1 _aWolters, Heiner
700 1 _aViebahn, Richard
700 1 _aTannapfel, Andrea
700 1 _aUhl, Waldemar
700 1 _aHengstler, Jan G
700 1 _aHahn, Stephan A
700 1 _aSiveke, Jens T
700 1 _aRauh, Daniel
773 0 _tCancer research
_gvol. 79
_gno. 9
_gp. 2367-2378
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-18-2861
_zAvailable from publisher's website
999 _c29464542
_d29464542